Search & Filter

A nationwide study of 4,000 pregnant women is to determine if delivering bigger babies earlier will prevent serious complications during labour and beyond.

Almost one in five (18%) women currently taking the epilepsy medication sodium valproate do not know it can potentially harm the development and physical health of their unborn child should they become pregnant. 

Heart failure rates are continuing to rise in the UK, mainly due to improved survival in people with coronary heart disease, particularly after myocardial infarction, and improved use of evidence-based therapies.

Hip fractures cost the NHS over £2 billion per year. Discharge planning can be met with significant delays and prolonged hospital stay. Planning care for these patients involves a multi-disciplinary approach with allied healthcare providers.

This article is based on a presentation given by Dr Chris Smith, Consultant in Diabetes and Endocrinology, RAH and Diabetes UK Clinical Champion, at the GM Conference Ageing and Healthcare Today, held in Edinburgh.

Research shows that end-of-life family carers have higher levels of anxiety, depression and general distress than other carers, and the general population.

New NICE guidance will help GPs, specialists and other health professionals spot a potential diagnosis of Lyme disease.

A study led the University of Warwick suggests that people are reluctant to use public access defibrillators to treat cardiac arrests.

Two ad hoc registries have recently been launched aimed at studying the epidemiology of non-tuberculous mycobacteria (NTM) pulmonary disease. 

Success rates for quitting smoking are at their highest level for a decade, according to a new report.

Treatment of heart attack patients depends on their history of cancer, according to research published in the European Heart Journal: Acute Cardiovascular Care.

People at the highest risk of type 2 diabetes should be given intensive exercise and weight loss help by the NHS, NICE has recommended.

The NHS and Public Health England (PHE) have announced a new initiative to prevent heart attacks and strokes, saving thousands of lives by taking a more integrated approach to cardiovascular care.

Around 1,300 lung cancer patients will receive nivolumab as part of a CDF deal put forward by makers Bristol-Myers Squibb.

Sponsored advertorial: Summary of article here - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.